The Pathologist / Issues / 2025 / September / Is it Time to Modernize Clinical Trials? / Notecards
Oncology Bioinformatics Oncology Precision medicine Molecular Pathology

Is it Time to Modernize Clinical Trials?

With millions of contextualized patient data records now available across oncology, clinical development needs to evolve for the precision medicine era, says Gen Li

By Helen Bristow 09/18/2025 Interview 6 min read

Share

0

  • Data-led approaches enhance oncology trial efficiency.

  • Real-world data aids in precise patient profiling.

  • Optimized protocol design can reduce burdens and improve recruitment.

  • Digital twins replicate patients to streamline trials.

  • Regulatory bodies support innovations in trial designs.

About the Author(s)

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Recommended